Richard Brook Sykes's most recent trade in PDS Biotechnology Corporation was a trade of 9,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) |